Ali Faraz 4
4 · Tenaya Therapeutics, Inc. · Filed Nov 17, 2025
Insider Transaction Report
Form 4
Ali Faraz
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-11-17$1.33/sh−3,126$4,158→ 299,666 total
Footnotes (2)
- [F1]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025.
- [F2]Includes 211,275 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.